Profil
David E.
Leahy was the founder of Molplex Ltd.
which was founded in 2010, where he held the title of Chief Executive Officer.
He also worked as a Principal at AstraZeneca PLC.
Prior to that, he was a Professor at The University of Newcastle from 2007 to 2010, where he held the title of Professor in 2010.
Ehemalige bekannte Positionen von David E. Leahy
| Unternehmen | Position | Ende |
|---|---|---|
| The University of Newcastle | Corporate Officer/Principal | 01.01.2010 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Molplex Ltd.
 Molplex Ltd. Pharmaceuticals: MajorHealth Technology Molplex Ltd. develops pharmaceutical drugs and ingredients. It focuses on medicines for cancer, infection, stratified medicine, autoimmune diseases and inflammation. Its Optiplex, a drug optimization platform estimates the outcomes of clinical trials integrated with laboratory operations for synthesis and screening. The company was founded in June 2010 and is headquartered in Macclesfield, the United Kingdom. | Vorstandsvorsitzender | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Molplex Ltd.
Molplex Ltd. Pharmaceuticals: MajorHealth Technology Molplex Ltd. develops pharmaceutical drugs and ingredients. It focuses on medicines for cancer, infection, stratified medicine, autoimmune diseases and inflammation. Its Optiplex, a drug optimization platform estimates the outcomes of clinical trials integrated with laboratory operations for synthesis and screening. The company was founded in June 2010 and is headquartered in Macclesfield, the United Kingdom. | Health Technology |
